The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 143 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R35 NS097966
NIA NIH HHS
Grant: U19 AG065169
NIA NIH HHS
Grant: P01 AG009973
NIA NIH HHS
Grant: R01 AG072643
National Institutes of Health
Grant: 1U19AG065169-01A1
Precision Aging Network: Closing the Gap Between Cognitive Healthspan andHuman Lifespan
National Institutes of Health
Grant: 5R35NS097966-06
De novo Synthesis and Memory
Fields of Study
MeSH Terms
Keywords
Additional file 1 of The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Additional file 1 of The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Additional file 1 of Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Additional file 1 of Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Additional file 2 of The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Additional file 2 of The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease